147 related articles for article (PubMed ID: 27889516)
1. Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma.
Vo MC; Anh-NguyenThi T; Lee HJ; Nguyen-Pham TN; Jaya Lakshmi T; Jung SH; Kim HJ; Lee JJ
Exp Hematol; 2017 Feb; 46():48-55. PubMed ID: 27889516
[TBL] [Abstract][Full Text] [Related]
2. Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma.
Nguyen-Pham TN; Jung SH; Vo MC; Thanh-Tran HT; Lee YK; Lee HJ; Choi NR; Hoang MD; Kim HJ; Lee JJ
J Immunother; 2015 Oct; 38(8):330-9. PubMed ID: 26325377
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model.
Vo MC; Yang S; Jung SH; Chu TH; Lee HJ; Lakshmi TJ; Park HS; Kim HJ; Lee JJ
Front Immunol; 2018; 9():1798. PubMed ID: 30123221
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide enhances anti-myeloma cellular immunity.
Luptakova K; Rosenblatt J; Glotzbecker B; Mills H; Stroopinsky D; Kufe T; Vasir B; Arnason J; Tzachanis D; Zwicker JI; Joyce RM; Levine JD; Anderson KC; Kufe D; Avigan D
Cancer Immunol Immunother; 2013 Jan; 62(1):39-49. PubMed ID: 22733396
[TBL] [Abstract][Full Text] [Related]
5. Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients.
Busch A; Zeh D; Janzen V; Mügge LO; Wolf D; Fingerhut L; Hahn-Ast C; Maurer O; Brossart P; von Lilienfeld-Toal M
Clin Exp Immunol; 2014 Aug; 177(2):439-53. PubMed ID: 24712857
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.
Toniolo PA; Liu S; Yeh JE; Moraes-Vieira PM; Walker SR; Vafaizadeh V; Barbuto JA; Frank DA
J Immunol; 2015 Apr; 194(7):3180-90. PubMed ID: 25725100
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties.
Costa F; Vescovini R; Bolzoni M; Marchica V; Storti P; Toscani D; Accardi F; Notarfranchi L; Dalla Palma B; Manferdini C; Manni S; Todaro G; Lisignoli G; Piazza F; Aversa F; Giuliani N
Oncotarget; 2017 Aug; 8(32):53053-53067. PubMed ID: 28881793
[TBL] [Abstract][Full Text] [Related]
8. Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells.
Yang M; Ma C; Sun J; Shao Q; Gao W; Zhang Y; Li Z; Xie Q; Dong Z; Qu X
Int Immunopharmacol; 2008 Dec; 8(13-14):1754-60. PubMed ID: 18783737
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.
Henry JY; Labarthe MC; Meyer B; Dasgupta P; Dalgleish AG; Galustian C
Immunology; 2013 Jul; 139(3):377-85. PubMed ID: 23374145
[TBL] [Abstract][Full Text] [Related]
10. Ex Vivo Induction of Multiple Myeloma-specific Immune Responses by Monocyte-derived Dendritic Cells Following Stimulation by Whole-tumor Antigen of Autologous Myeloma Cells.
Vasileiou S; Baltadakis I; Delimpasi S; Karatza MH; Liapis K; Garofalaki M; Tziotziou E; Poulopoulou Z; Karakasis D; Harhalakis N
J Immunother; 2017 Sep; 40(7):253-264. PubMed ID: 28763347
[TBL] [Abstract][Full Text] [Related]
11. Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway.
Li J; Wang X; Wang W; Luo J; Aipire A; Li J; Zhang F
Vaccine; 2015 Apr; 33(16):1923-33. PubMed ID: 25748337
[TBL] [Abstract][Full Text] [Related]
12. Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma.
Nguyen-Pham TN; Im CM; Nguyen TA; Lim MS; Hong CY; Kim MH; Lee HJ; Lee YK; Cho D; Ahn JS; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
Leuk Res; 2011 Sep; 35(9):1241-7. PubMed ID: 21612823
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib Exerts
Ocadlikova D; Lecciso M; Broto JM; Scotlandi K; Cavo M; Curti A; Palmerini E
Front Immunol; 2021; 12():577766. PubMed ID: 33717062
[TBL] [Abstract][Full Text] [Related]
14. Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma.
Neuber B; Herth I; Tolliver C; Schoenland S; Hegenbart U; Hose D; Witzens-Harig M; Ho AD; Goldschmidt H; Klein B; Hundemer M
J Immunol; 2011 Jul; 187(2):1047-56. PubMed ID: 21677134
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.
Jung SH; Lee YK; Lee HJ; Choi NR; Vo MC; Hoang MD; Lim MS; Nguyen-Pham TN; Kim HJ; Lee JJ
Exp Hematol; 2014 Apr; 42(4):274-81. PubMed ID: 24407159
[TBL] [Abstract][Full Text] [Related]
16. Decline in Immunological Responses Mediated by Dendritic Cells in Mice Treated with 18α-Glycyrrhetinic Acid.
Ebrahimnezhad S; Amirghofran Z; Karimi MH
Immunol Invest; 2016; 45(3):191-204. PubMed ID: 27018762
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators of lenalidomide for multiple myeloma: consensus and controversy.
Kuroda J; Kobayashi T; Taniwaki M
Expert Rev Anticancer Ther; 2015; 15(7):787-804. PubMed ID: 25947283
[TBL] [Abstract][Full Text] [Related]
18. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.
Della Bella S; Nicola S; Riva A; Biasin M; Clerici M; Villa ML
J Leukoc Biol; 2004 Jan; 75(1):106-16. PubMed ID: 14525963
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immunomodulatory effects of Boswellia sacra essential oil on T-cells and dendritic cells.
Aldahlawi AM; Alzahrani AT; Elshal MF
BMC Complement Med Ther; 2020 Nov; 20(1):352. PubMed ID: 33213426
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide.
Yamamoto K; Kitawaki T; Sugimoto N; Fujita H; Kawase Y; Takaori-Kondo A; Kadowaki N
Immunol Lett; 2019 Jul; 211():41-48. PubMed ID: 31141702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
